Regine Mayer‐Steinacker

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

Wolfgang Wick, Michael Platten, Christoph Meisner et al. · The Lancet Oncology · 2012 · 1.1K citations · Full text

Neuro-oncology, Temozolomide Chemotherapy, Malignant Astrocytoma +9

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan et al. · European Journal of Cancer · 2019 · 700 citations · Full text

Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group

Toshifumi Ozaki, Silke Flege, Matthias Kevric et al. · Journal of Clinical Oncology · 2003 · 341 citations

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O⁶-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial

Ulrich Herrlinger, Niklas Schäfer, Astrid Weyerbrock et al. · Journal of Clinical Oncology · 2016 · 194 citations

Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide

G. Dresemann, Michael Weller, Mark Rosenthal et al. · Journal of Neuro-Oncology · 2009 · 153 citations

Neuro-oncology, Oncology, Medicine +9